Literature DB >> 9667613

A fistful of T cells.

R J Moots1.   

Abstract

Evidence incriminating T cells in rheumatoid arthritis (RA) is strong but circumstantial--like a smoking gun at the scene of a crime. To investigate this, T lymphocytes were studied in health and disease. The effect of mutations in the groove of HLA-A2 on peptide presentation to T cells was studied to investigate normal T cell function. This allowed a detailed description of the interactions between individual MHC residues and antigens. Subsequently, T cells in the autoimmune disease, multiple sclerosis, were studied, to investigate the mechanisms for breakdown in peripheral tolerance. T-cell clones that recognized both autoantigens and viral proteins were isolated, suggesting that infection may trigger disease. Autoantigens would need to be defined to use this strategy in RA. T-cell responses to type II collagen, a candidate auto-antigen, were therefore studied in RA and an epitope successfully defined. The search for microbial 'mimics' triggering RA, and novel forms of immunotherapy are now possible--with potential rehabilitation of T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667613      PMCID: PMC7793156          DOI: 10.1093/rheumatology/37.6.602

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  3 in total

Review 1.  From Shakespeare to Star Trek and beyond: a Medline search for literary and other allusions in biomedical titles.

Authors:  Neville W Goodman
Journal:  BMJ       Date:  2005-12-24

Review 2.  Genistein: the potential for efficacy in rheumatoid arthritis.

Authors:  Jinchao Li; Dong Gang; Xiaowei Yu; Yiping Hu; Ye Yue; Wenxiang Cheng; Xiaohua Pan; Peng Zhang
Journal:  Clin Rheumatol       Date:  2013-01-10       Impact factor: 2.980

3.  Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis.

Authors:  Loes Linsen; Marielle Thewissen; Kurt Baeten; Veerle Somers; Piet Geusens; Jef Raus; Piet Stinissen
Journal:  Arthritis Res Ther       Date:  2005-02-18       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.